Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Stomach Neoplasms 2Colonic Neoplasms 2Sarcoma 1Rectal Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1HER2 IHC3+ Advanced Colorectal Cancer 1Colorectal Cancer Metastatic 1Advanced Malignancies 1

Interventions

Specimen Handling 43pembrolizumab 42Biopsy 36Magnetic Resonance Spectroscopy 34Paclitaxel 21Carboplatin 21Gemcitabine 20Nivolumab 19Irinotecan 17Radiosurgery 15Cisplatin 13Taxes 11Pemetrexed 11Ipilimumab 11Fluorouracil 11Cetuximab 11130-nm albumin-bound paclitaxel 11trastuzumab deruxtecan 10olaparib 10Leucovorin 10Capecitabine 10abemaciclib 9Oxaliplatin 9Cyclophosphamide 9Bevacizumab 9palbociclib 8durvalumab 8Fulvestrant 8X-Rays 7Trastuzumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × HMPL-013 × 90 days × Clear all
NCT07042685 2026-04-09

Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer

The Methodist Hospital Research Institute

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡